Skip to main content

News Archive

News Archive - Jacobs School of Engineering

Google Selects UC San Diego Computer Science Professor and Alumni for Faculty Research Awards

February 18, 2016

Google has announced two new Google Faculty Research Awards to CSE alumni and one to CSE Prof. Ravi Ramamoorthi in the Jacobs School of Engineering of the University of California, San Diego. It is Ramamoorthi's second such award, after receiving one in 2014 while he was still at UC Berkeley (just months before he joined the CSE faculty at UC San Diego). In 2015 CSE Prof. Steven Swanson was the sole recipient at UC San Diego of the Faculty Research Award.

Events, Activities Emphasize Importance of Ethics for Scholars and Scientists

February 17, 2016

As a public research university, UC San Diego is committed to the highest standards of integrity in research.

Presidential Advisor John Holdren to Speak at UC San Diego

February 17, 2016

John Holdren, President Barack Obama’s senior science and technology advisor, will speak at the University of California, San Diego for the fifth annual Herb York Memorial Lecture on Monday, Feb. 29. A keynote event for the UC Institute on Global Conflict and Cooperation (IGCC), the visit is cosponsored by the School of Global Policy and Strategy and Jacobs School of Engineering.

A New Method to Dramatically Improve the Sequencing of Metagenomes

February 16, 2016

An international team of computer scientists developed a method that greatly improves researchers’ ability to sequence the DNA of organisms that can’t be cultured in the lab, such as microbes living in the human gut or bacteria living in the depths of the ocean. They published their work in the Feb. 1 issue of Nature Methods.

Engineers 3D-print a New Lifelike Liver Tissue for Drug Screening

February 8, 2016

A team led by engineers at the University of California, San Diego has 3D-printed a tissue that closely mimics the human liver’s sophisticated structure and function. The new model could be used for patient-specific drug screening and disease modeling. Researchers said the advance could help pharmaceutical companies save time and money when developing new drugs.

UC San Diego Launches New Nonalcoholic Fatty Liver Disease Research Center

February 8, 2016

Roughly one-quarter of all Americans – an estimated 100 million adults and children – have nonalcoholic fatty liver disease (NAFLD), a chronic condition that can lead to cirrhosis, liver cancer and liver failure. Combining a diverse array of basic science, biomarkers, imaging and clinical efforts, University of California, San Diego School of Medicine has launched a new NAFLD Research Center to better understand the disease and develop treatments where none currently exist.

New Algorithm Improves Speed and Accuracy of Pedestrian Detection

February 8, 2016

Electrical engineers at the University of California, San Diego have developed a pedestrian detection system that performs in near real-time and with higher accuracy than existing systems. The technology, which incorporates deep learning models, could be used in “smart” vehicles, robotics and image and video search systems.

UC San Diego Researchers Cited Among “World’s Most Influential Scientific Minds”

February 1, 2016

Twenty-two University of California, San Diego scientists and physicians are among the 2015 listing of “The World’s Most Influential Scientific Minds,” an annual compendium of “Highly Cited Researchers” by Thomson Reuters, a multinational mass media and information company.

Online Course on Mastering the Software Engineering Interview

January 28, 2016

Three computer-science faculty at UC San Diego have developed an online course on the Coursera platform that aims to help tech learners master the art of acing a software engineering job interview.

New Biomarker Identifies Colon Cancer Patients Who May Benefit from Chemotherapy

January 20, 2016

Using a new computer science approach, researchers at University of California, San Diego School of Medicine, Columbia University and Stanford University discovered a distinctive molecular feature — a biomarker — that identified colon cancer patients who were most likely to remain disease-free up to five years after surgery. The biomarker, a protein called CDX2, also helped the researchers identify Stage II colon cancer patients who are most likely to benefit from chemotherapy after surgery.
Category navigation with Social links